Integra LifeSciences Holdings Corporation - Common Stock (IART) stock analysis

IART · Integra LifeSciences Holdings Corporation - Common Stock

Latest recorded price: USD 13.98

Sector and industry: Healthcare · Medical Devices

Fiscal 2025 figures: revenue growth 1.6%, free cash flow margin -1.9%, ROIC -27.3%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare